Own and run the kaizen funnel for your value stream: prioritize, charter, and lead kaizen events and workshops that close KPI gaps in titer and yield stability, fermentation reproducibility, downstream recovery and purification yield, right-first-time execution, changeover through SMED, and the manufacturing-to-quality handoff. BioVectra, now part of Agilent’s Advanced Therapeutics Division (ATD), is a CDMO producing active pharmaceutical ingredients at clinical-to-commercial scale across microbial fermentation, small molecules, plasmid DNA, mRNA, LNP, and sterile fill, operating from Charlottetown, PEI and Windsor, Nova Scotia.